Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial
Article in ESMO Open (April 2024)
The most recent citing publications are shown below. View all 66 publications that cite this research output on Dimensions.
Mitotic Catastrophe Heterogeneity: Implications for Prognosis and Immunotherapy in Hepatocellular Carcinoma
Preprint in Research Square (January 2024)
Breaking Barriers in Neuro-Oncology: A Scoping Literature Review on Invasive and Non-Invasive Techniques for Blood–Brain Barrier Disruption
Article in Cancers (January 2024)